Sponsor Attestation Checklist for Abbreviated New Drug Submissions (ANDS) and Supplements to an Abbreviated New Drug Submission (SANDS)

First Page		Document Content
Date: 2014-01-06 12:53:57 Pharmacology Clinical research Pharmacokinetics Validity Abbreviated New Drug Application Bioequivalence Bioavailability Food and Drug Administration Geometric dimensioning and tolerancing Pharmaceutical sciences Pharmaceutical industry Pharmaceutics		Sponsor Attestation Checklist for Abbreviated New Drug Submissions (ANDS) and Supplements to an Abbreviated New Drug Submission (SANDS) Add to Reading List Source URL: www.hc-sc.gc.ca Download Document from Source Website File Size: 60,99 KB Share Document on Facebook

	Investigator Responsibilities in Protecting Participants in the Conduct of Bioequivalence Studies Cecilia C. Maramba, MD, MScID DocID: 1ptht - View Document
	PUBLIC LAW 105–115—NOV. 21, 1997 FOOD AND DRUG ADMINISTRATION MODERIZATION ACT OF 1997 111 STAT. 2296 DocID: 1pnIy - View Document
	Updating ANDA Labeling After the Marketing Application for the Reference Listed Drug Has Been Withdrawn Guidance for Industry DocID: 1p93k - View Document
	Case 2:06-cvHAA-ES Document 71 FiledPage 1 of 45 PageID: 1673 NOT FOR PUBLICATION UNITED STATES DISTRICT COURT DocID: 1m2hg - View Document
	Microsoft Word - 10CV5118 Seattle Childrens Hosp v Akorn MTD.doc DocID: 1lmCl - View Document